S100A12 expression in patients with primary biliary cirrhosis

References

• Abe J, Jibiki T, Noma S, et al. (2005). Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol, 174, 5837–45
   PubMed Web of Science ®Google Scholar
• Afford SC, Ahmed-Choudhury J, Randhawa S, et al. (2001). CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J, 15, 2345–54
   PubMed Web of Science ®Google Scholar
• Baillet A, Trocme C, Berthier S, et al. (2010). Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology, 49, 671–82
   PubMed Web of Science ®Google Scholar
• Bao G, Han Z, Yan Z, et al. (2010). Increased Siglec-1expression in monocytes of patients with primary biliary cirrhosis. Immunol Investig, 39, 645–60
   PubMed Web of Science ®Google Scholar
• Bovin LF, Rieneck K, Workman C, et al. (2004). Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol Lett, 93, 217–26
   PubMedGoogle Scholar
• De Sanctis JB, Zabaleta M, Bianco NE, et al. (2009). Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity, 42, 272–4
   PubMed Web of Science ®Google Scholar
• Dickson ER, Grambsch PM, Fleming TR, et al. (1989). Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology, 10, 1–7
   PubMed Web of Science ®Google Scholar
• Brinar M, Cleynen I, Coopmans T, et al. (2010). Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut, 59, 1728–9
   PubMed Web of Science ®Google Scholar
• Foell D, Ichida F, Vogl T, et al. (2003a). S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet, 361, 1270–2
   PubMed Web of Science ®Google Scholar
• Foell D, Kucharzik T, Kraft M, et al. (2003b). Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut, 52, 847–53
   PubMed Web of Science ®Google Scholar
• Fu S, Gong F, Xie C, et al. (2010). S100A12 on circulating endothelial cells surface in children with Kawasaki disease. Pediatr Res, 68, 165–8
   Google Scholar
• Han EC, Cho SB, Ahn KJ, et al. (2011). Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behcet's Disease and its association with disease activity: A pilot study. Ann Dermatol, 23, 313–20
   PubMed Web of Science ®Google Scholar
• Harada K, Nakanuma Y. (2006). Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol, 39, 55–61
   Google Scholar
• Harada K, Ozaki S, Gershwin ME, Nakanuma Y. (1997). Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology, 26, 1399–405
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Drury S, Fu C, et al. (1999). RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell, 97, 889–901
   PubMed Web of Science ®Google Scholar
• Invernizzi P, Crosignani A, Battezzati PM, et al. (1997). Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology, 25, 1090–5
   PubMed Web of Science ®Google Scholar
• Invernizzi P, Selmi C, Gershwin ME. (2010). Update on primary biliary cirrhosis. Digest Liver Dis, 42, 401–8
   Google Scholar
• Liang Y, Yang Z, Li C, et al. (2008). Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis. Clin Exper Med, 8, 1–7
   PubMedGoogle Scholar
• Lindor KD, Gershwin ME, Poupon R, et al. (2009). Primary biliary cirrhosis. Hepatology, 50, 291–308
   PubMed Web of Science ®Google Scholar
• Mao TK, Lian ZX, Selmi, C, et al. (2005). Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology, 42, 802–8
   PubMedGoogle Scholar
• Meijer B, Gearry RB, Day AS. (2012). The role of S100A12 as a systemic marker of inflammation. Inter J Inflam, 2012, 1
   Google Scholar
• Miura T, Ouchida R, Yoshikawa N, et al. (2001). Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid. J Biol Chem, 276, 47371–8
   PubMed Web of Science ®Google Scholar
• Pietzsch J, Hoppmann S. (2009). Human S100A12: A novel key player in inflammation? Amino Acids, 36, 381–9
   PubMed Web of Science ®Google Scholar
• Qi Y, Gong F, Zhang Q, et al. (2012). Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease. Arthrit Res Ther, 14, R251
   Google Scholar
• Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. (2010). Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol, 53, 318–25
   PubMed Web of Science ®Google Scholar
• Selmi C, Meda F, Kasangian A, et al. (2010). Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol, 7, 1–10
   Google Scholar
• Shindo M, Mullin GE, Braun-Elwert L, et al. (1996). Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exper Immunol, 105, 254–9
   Google Scholar
• Van de Logt F, Day AS. (2013). S100A12: A noninvasive marker of inflammation in inflammatory bowel disease. J Digest Dis, 14, 62–7
   Google Scholar
• Yang Z, Tao T, Raftery MJ, et al. (2001). Proinflammatory properties of the human S100 protein S100A12. J Leukocyte Biol, 69, 986–94
   PubMed Web of Science ®Google Scholar
• Yokomori H, Oda M, Wakabayashi G, et al. (2003a). Ursodeoxycholic acid therapy attenuated expression of adhesion molecule in primary biliary cirrhosis. Inter Med, 42, 1259–61
   Web of Science ®Google Scholar
• Yokomori H, Oda M, Yoshimura K, et al. (2003b). Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 protein and messenger RNA in primary biliary cirrhosis. Intern Med, 42, 947–54
   Google Scholar
• Zhao J, Zhao S, Zhou G, et al. (2011). Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis. Scand J Gastroenterol, 46, 485–94
   PubMed Web of Science ®Google Scholar